Pharmacy Advocacy Center
Ron Lanton, who is NPSC’s legal counsel and in-house Advocacy Director, is overseeing this section of our site. Network participants will get alerts on issues that matter. If you have any questions, you can reach Mr. Lanton by phone at (240) 482-6060 or by email rlanton@lantonlaw.com.
The materials and information provided in this site are for informational purposes only and not for the purpose of providing legal advice. Use of and access to this presentation or any of the materials or information contained within this presentation do not create an attorney-client relationship between Lanton Law and the user or viewer. You should contact your attorney to obtain advice with respect to any issue or problem
New Proposed FDA Compounding Rule
Pharmacy Industry Launches Another PBM Lawsuit
NPSC Advocacy Center Flags Advancing PBM Bill
DIR Class Action Lawsuit Contact Information
Mass Face of Pharmacy Day
NPSC & IPC Hold Joint Meeting with Senator Markey’s Office
FDA Released Guidance for Pharmacies Regarding DSCSA
Draft FTC-DOJ Merger Guidelines
Pharmacy Collective Bargaining Exemption to Current Antitrust Laws
HD4325/1425: An Act Relative to Pharmacists as Healthcare Providers
2023 Q3 Analysis: What NPSC Pharmacies Need to Know
Expo 2023 Follow Up by Ron Lanton
CMS Finalizes DIR Fee Proposal But More Changes Are Needed
NPSC’s Comments to the Federal Trade Commission
Court Stay Granted in Federal DIR Litigation
Legislation Strengthening Pharmacy Provider Status
New Pro-Pharmacy Legislation Introduced in Congress
NCPA’s DIR Fee Education Video
NPSC’s Comments to Support “An Act Investing in the Future of Our Health”
NPSC’s Comments to CMS on DIR Fees
Pharmacy Advocacy Center Skinny Label Litigation
Legislative Affairs